| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Upjohn Company, Research Division, Kalamazoo, Michigan 49001
The ability of a small proportion of the cells in cultures of Detroit-98 (D-98) human sternal marrow cells to attach to glass in the presence of 8-azaguanine has been previously shown to be caused by a mutation to resistance to this compound. This paper presents results of experiments dealing with the effect of the addition of quinacrine hydrochloride to the culture medium of D-98 cells on the frequency of this mutation. Such cells have been previously shown to be azaguanine-resistant mutants. In three independent experiments, cultures which were grown for several subcultivations in the presence of 0.06 µg/ml of quinacrine hydrochloride contained one-half to one-third the mean number of azaguanine-resistant mutants found in control cultures. On the other hand, the incorporation of quinacrine hydrochloride into the culture medium of D-98/AG cells, an azaguanine-resistant subline of the D-98 line, had no effect on its cloning efficiency in the presence or absence of added azaguanine. The results are discussed as a possible confirmation of the proposed antimutagenic action of quinacrine hydrochloride on mammalian cells.
1 Present address: Department of Microbiology, University of Michigan, School of Medicine, Ann Arbor, Michigan.
2 All correspondence should be addressed to this author.
Received 11/18/68. Accepted 3/18/69.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |